A Study of CA-4948 in Patients With Relapsed or Refractory Hematologic Malignancies



Status:Recruiting
Conditions:Lymphoma, Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:1/23/2019
Start Date:December 28, 2017
End Date:December 2021
Contact:Robert Martell, MD
Email:clinicaltrials@curis.com
Phone:617-503-6500

Use our guide to learn which trials are right for you!

An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients With Relapsed or Refractory Hematologic Malignancies

This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult
patients with Relapsed or Refractory Hematologic Malignancies. The trial will be conducted in
2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or
Refractory Hematologic Malignancies, and a Dose Expansion Phase (Part B) of CA-4948 in
patients with selected RR hematologic malignancies (including NHL with and without myeloid
differentiation primary response 88 (MYD88) mutations, and AML).


Inclusion Criteria:

1. Males and females greater than or equal to 18 years of age

2. Life expectancy of at least 3 months

3. Eastern Cooperative Oncology Group (ECOG) Performance Status of ≤ 1

4. Diagnosis of histopathologically confirmed hematologic malignancies. For NHL:
Confirmed B-cell NHL (as per the World Health Organization [WHO] 2016 classification
including WM/LPL). For AML: Diagnosis of histopathologically confirmed AML (as per the
World Health Organization [WHO] 2016 classification; Owen 2013) that is relapsed
and/or refractory.

5. Relapsed or refractory disease for which patients are ineligible for or have exhausted
standard therapeutic options that would be considered standard of care

Exclusion Criteria:

1. Active central nervous system (CNS) involvement of their malignancy.

2. Radiotherapy delivered to non-target lesions within one week prior to starting study
treatment or delivered to target lesions that will be followed on the study (NOTE:
prior sites of radiation will be recorded)

3. History of allogeneic stem cell transplant for NHL

4. Any prior anti-cancer treatment such as chemotherapy, immunomodulatory drug therapy,
etc., received within 14 days prior to start of CA-4948

5. Current or planned glucocorticoid therapy, with the following exceptions:

1. Doses ≤ 10 mg/day prednisolone or equivalent is allowed, provided that the
steroid dose has been stable or tapering for at least 14 days prior to the first
dose of CA-4948

2. Inhaled, intranasal, intraarticular and topical steroids are permitted

6. Use of any investigational agent within 28 days or 5 half-lives, whichever is shorter,
prior to start of CA-4948

7. Presence of an acute or chronic toxicity resulting from prior anti-cancer therapy,
with the exception of alopecia, that has not resolved to Grade ≤ 1 within 7 days prior
to start of CA-4948 unless approved by the Medical Monitor

8. Known allergy or hypersensitivity to any component of the formulation of CA-4948 used
in this study

9. Diagnosis of acute promyelocytic leukemia (APL, M3) for AML

10. Hematopoietic stem cell transplant (HSCT) within 60 days of the first dose of CA-4948
for AML

11. Blast transformation of CML into AML
We found this trial at
10
sites
New Haven, Connecticut 06520
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
4201 Belfort Road
Jacksonville, Florida 32216
(408) 293-2336
Mayo Clinic Mayo Clinic's campus in Arizona provides medical care for thousands of people from...
2135
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
2430
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
505 South 45th Street
Omaha, Nebraska 68198
1298
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
5777 East Mayo Boulevard
Phoenix, Arizona 85054
(480) 515-6296
Mayo Clinic Mayo Clinic's campus in Arizona provides medical care for thousands of people from...
347
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Rochester, Minnesota 55905
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Seattle, Washington 98104
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials